Funding for this research was provided by:
INSERM
Association Monégasque contre les myopathies
Duchenne Parent Project France
Article History
First Online: 1 August 2020
Change Date: 4 August 2020
Change Type: Correction
Change Details: The second author, which currently reads as: Adeline Vulin-Chaffiol.
Compliance with Ethical Standards
:
: AV is an employee of SQY therapeutics, developing tcDNA-ASOs. AG and FB declare no conflict of interest.
: Authors are supported by the Institut National de la santé et la recherche médicale (INSERM), the Association Monegasque contre les myopathies (AMM), the Duchenne Parent project France (DPPF) and the Fondation UVSQ. AV is an employee of SQY therapeutics.